FDA Approved: XADAGO — Supplemental Application (MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for XADAGO (safinamide mesylate) from MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Xadago (safinamide)

Snippet

SUPPL AP for XADAGO (SAFINAMIDE MESYLATE)